ACETAMINOPHEN; HYDROCODONE BITARTRATE | A202991 | RHODES PHARMACEUTICALS LP
Highest NADAC/Unit
$0.1531
per ea
Lowest NADAC/Unit
$0.1351
per ea
Brand NDCs
0
Generic NDCs
5
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 42858020301HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET | $0.1531 | EA | Generic | — | 2026-06-17 |
| 42858020350HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET | $0.1531 | EA | Generic | — | 2026-06-17 |
| 42858020201HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET | $0.1389 | EA | Generic | — | 2026-06-17 |
| 42858020101HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET | $0.1351 | EA | Generic | — | 2026-06-17 |
| 42858020150HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET | $0.1351 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.